EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

Buda Juice, Inc. (BUDA) fair value: what the stock is really worth

As of Sep 23, 2026: fair value of Buda Juice, Inc. $8.06, price $7.55, upside +6.8%, quality 81 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Consumer Defensive · US · ISIN US11882T1060

BJ Buda Juice, Inc. logo Broad data Sep 24, 2026

Buda Juice, Inc.

BUDA · US

Quality WatchlistQuality growthA strong company, but the current price is close to Fair Value.

·Fair value $8.06 · Fairly valued (+7%)
✓Quality 81/100
✓Healthy Growth (revenue YoY +11.8 %/yr)
✓Solidly profitable · 17.2% net margin (TTM)
✓generates free cash flow
!Mixed vs. peers (7/13)
!Moderate moat 64/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

$10.86 $7.16 Fair Value $8.06 Jan 2026 Sep 2026

White line = price, green steps = our fair value per fiscal year. As of Sep 24, 2026.

How to read this chart

9‑month range $7.16 – $10.86 · fair‑value band $5.00 – $13.24 · the $7.55 price screens below the $8.06 fair value. As of Sep 24, 2026.

Follow Buda Juice in your weekly email

Every Wednesday you see whether Buda Juice is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

Buda Juice, Inc. engages in producing and distributing juice, lemonades, limeades, and wellness shots in the United States. The company offers clean-label beverages; citrus juices; and cold-pressed juices made from fruits and vegetables. The company serves wholesale clients. The company was incorporated in 2013 and is headquartered in Dallas, Texas.

Stock analysis

Buda Juice, Inc. (BUDA) currently trades at $7.55, while our model-based Fair Value estimate is $8.06, implying the stock looks roughly 6.3% fairly valued today.

Show more

Valuation

Bull case: the Growth Earnings group reads highest at a median of $5.77 per share, and 1 of the 24 models we run sit above the $7.55 price.

Bear case: the Multiples group reads lowest at $1.65, and 23 of the 24 models stay below the price. Evidence for this calculation is high.

Scenario range: $5.00 (bear) to $13.24 (bull), the price of $7.55 sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 81/100 (high quality), in the Consumer Defensive sector.

Healthy Growth: Revenue growth appears healthy and is supported by profitability and cash-flow quality.

Buda Juice, Inc. reported revenue of $12.6M in FY2025 versus $9.4M in FY2023, a compound +15.9%/yr. Reported net income was $3.5M in FY2025, compounding +25.0%/yr from FY2023.

Key figures

Market cap $94.9M · P/E ratio 39.7 · P/S ratio 11.1 · EPS (TTM) $0.1900 · Dividend yield 3.0% · Net margin 28.0% · Return on equity 19.3% · Return on assets (EBIT) 80.7%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 52 out of 100 (low confidence).

What moves the price

For context, the median of 10 Consumer Defensive peers we cover trades at 10% fair-value upside, at 7%, BUDA screens richer than that median.

Fair Value models

Bear $5.00 Fair Value $8.06 Bull $13.24
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Based on fiscal year 2025 figures (about 9 months old). Earnings retained since then ($0.1395 per share) are deliberately not added. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF $2.44 $3.97 $6.26 70
EPV $1.70 $1.88 $2.03 68
Growth DCF $2.38 $3.66 $5.43 68
All 24 models by family
DCF Models
FCF DCF $2.44 $3.97 $6.26 70
Owner Earnings $3.01 $4.92 $7.79 65
5Y Revenue Exit $1.68 $2.56 $3.72 63
5Y EBITDA Exit $2.68 $4.70 $7.26 64
5Y P/E Exit $3.49 $6.41 $9.85 60
10Y Revenue Exit $1.93 $2.82 $4.12 58
10Y EBITDA Exit $2.54 $4.18 $6.73 58
10Y P/E Exit $3.00 $5.27 $8.64 54
Earnings-Based
Graham-Dodd $1.91 $9.85 $13.62 57
Lynch FV $2.69 $3.84 $5.00 55
PEG = 1.0 $2.69 $3.84 $5.00 52
EPV $1.70 $1.88 $2.03 68
Multiples
P/E Multiple $4.43 $5.90 $7.38 63
P/S Multiple $1.20 $1.61 $2.01 58
P/B Multiple $1.23 $1.64 $2.04 55
EV/EBIT $3.65 $4.81 $5.98 63
EV/EBITDA $3.10 $4.09 $5.07 64
EV/Revenue $1.20 $1.65 $2.10 51
Asset-Based
NCAV (Graham) $0.1500 $0.2000 $0.3000 51
Growth DCF
Growth DCF $2.38 $3.66 $5.43 68
Rev-Margin DCF $1.68 $2.56 $3.75 63
Economic Profit
Residual Income $1.25 $2.13 $38.63 57
ROIC Compounder $1.75 $2.01 $2.26 64
Growth Earnings
Growth-Adj P/E $4.04 $5.77 $7.51 61

Open the full fair value analysis →

Notify me when BUDA reaches fair value

Put BUDA on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 81/100

Of which business quality 81 · Market factors (momentum, volatility) 21

Profitability 100
Margins and returns on capital today
Quality Growth 18
Are margins and returns improving?
Cashflow 75
Earnings quality: real cash, not paper profit
Fin. Strength 100
Balance sheet, leverage, solvency risk
Investment 100
Disciplined investing over empire-building
Low Volatility 0
Calm price path (market factor)
Momentum 27
Price trend over the last 3–12 months (market factor)
52W Momentum 34
Distance to the 52-week high (market factor)
Net Issuance 83
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 95/100
Revenue growth appears healthy and is supported by profitability and cash-flow quality.
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: only 3 usable fiscal years, at least 4 required
not computed

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+26.1%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (USA: IMF forecast 2.4% a year to 2030, 3.1% from 2016 to 2025) that is about +23.2% a year for the price.

Watch BUDA, get fair value alerts →

Compare Buda Juice, Inc. with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Beverages - Non-Alcoholic · 91 stocks

Beats the industry median on 7/13 measures
A mixed picture versus its industry peers.
Valuation
Quality Score 81 · Top 25%
Fair Value upside +7% · Above median
Profitability
Return on equity (TTM) 19% · Top 25%
Return on assets 11% · Top 25%
Net margin (TTM) 17% · Top 25%
Operating margin (TTM) 10% · Below median
Growth and dividend
Revenue growth 26% · Top 25%
Dividend yield (TTM) 3.0% · Above median

Valuation Multiplesvs Beverages - Non-Alcoholic median · lower = cheaper

P/E (TTM) 39.7× · Priciest 25%
P/B 25.38× · Priciest 25%
P/S (TTM) 6.74× · Priciest 25%
P/FCF 32.7× · Priciest 25%
EV/EBITDA 33.9× · Priciest 25%

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)42 · sector 29
FUTURE (revenue growth)100 · sector 50
PAST (return on equity)77 · sector 50
HEALTH (low debt)0 · sector 95
DIVIDEND (yield)61 · sector 55

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

Alcohol

Similar stocks

10 more Beverages - Non-Alcoholic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
The Coca-Cola Company KO $88.61 $29.32 −67%
PepsiCo, Inc PEP $130.18 $96.95 −26%
Monster Beverage Corporation MNST $43.91 $56.09 +28%
Nongfu Spring Co 9633 HK$38.98 HK$42.88 +10%
Coca-Cola Europacific Partners PLC CCEP $102.31 $85.26 −17%
Keurig Dr Pepper Inc KDP $31.76 $40.34 +27%
Coca-Cola FEMSA, S.A. KOF $110.57 $108.02 −2%
Varun Beverages Limited VBL ₹430.20 ₹187.49 −56%
Eastroc Beverage (Group) Co 605499 ¥115.45 ¥173.16 +50%
MIXUE Group 2097 HK$189.20 HK$431.36 +128%

Explore undervalued stocks

More undervalued Consumer Defensive stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "Buda Juice, Inc. Fair Value". https://www.fairvalue-calculator.com/stock/BUDA

Frequently asked questions

Is Buda Juice, Inc. (BUDA) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $8.06 versus a price of $7.55, about +7% upside (fairly valued).
What is the fair value of BUDA?
Our model-based fair value for Buda Juice, Inc. is $8.06 (as of Sep 24, 2026), built from audited fundamentals. The current price: $7.55.
What is the quality score of BUDA?
Buda Juice, Inc. has a Quality Score of 81/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Buda Juice, Inc. (BUDA)?
Our model-based price target is the fair value of $8.06 (as of Sep 24, 2026) from 24 valuation models. Cautious scenario $5.00, optimistic scenario $13.24. It is a calculation from audited fundamentals, not an analyst target.
What is the Buda Juice, Inc. stock forecast for 2026?
Our models put fair value at $8.06, about +7% upside versus a price of $7.55 (fairly valued). Cautious scenario $5.00, optimistic scenario $13.24. The calculation is refreshed regularly with new filings.
What is the revenue of Buda Juice, Inc. (BUDA)?
Buda Juice, Inc. reported trailing-twelve-month revenue of about $14.1M (latest available figure, as of Sep 24, 2026).
Does Buda Juice, Inc. pay a dividend?
Buda Juice, Inc. currently shows a dividend yield of about 3.03% relative to its recent price (as of Sep 24, 2026).
What growth is priced into Buda Juice, Inc. (BUDA)?
For today's price to be fair in a discounted-cash-flow model, Buda Juice, Inc. would have to grow free cash flow by +26.1 % per year for five years (discount rate 12.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 2 years revenue grew +15.9 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of BUDA use?
Our models discount Buda Juice, Inc. at 12.7 %: a base by market capitalisation (micro), country premium for USA. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For Buda Juice, Inc. that is +26.1 % per year a year over ten years, using the same discount rate (12.7 %) and the same formula as our fair value.
How much growth has Buda Juice, Inc. (BUDA) delivered so far?
Over the past 2 years revenue at Buda Juice, Inc. grew +15.9 % a year. The price currently implies +26.1 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of Buda Juice, Inc. (BUDA) growing?
The median revenue growth in the sector is +2.9 % a year. That is the yardstick for the growth priced into Buda Juice, Inc. (+26.1 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of Buda Juice, Inc. (BUDA)?
The free-cash-flow yield on the price is 3.06 %: that much free cash flow Buda Juice, Inc. produces per unit of market value. When it exceeds the discount rate of our models (12.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of Buda Juice, Inc. (BUDA)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Buda Juice, Inc. it is $8.06 per share (as of Sep 24, 2026), against a price of $7.55. It is the blended result of 24 valuation models (cash flow, earnings, asset, dividend).
Is Buda Juice, Inc. stock overvalued or undervalued in 2026?
As of Sep 24, 2026, BUDA trades below its calculated fair value: price $7.55, fair value $8.06, a gap of about +7% (fairly valued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of BUDA?
No. The price is what the market pays today ($7.55); the fair value is what the company's own numbers justify ($8.06). For Buda Juice, Inc. the two are $0.5100 per share apart. That gap is exactly why we show both numbers side by side.
How much is Buda Juice, Inc. worth?
The market values Buda Juice, Inc. at about $94.9M (market capitalisation, as of Sep 24, 2026). Per share that is $7.55; our models calculate a fair value of $8.06 per share.
What do the bullish and bearish scenarios say about BUDA?
Our models span a range for Buda Juice, Inc.: cautious scenario $5.00, base $8.06, optimistic $13.24 per share (as of Sep 24, 2026, price $7.55). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of BUDA?
Buda Juice, Inc. trades at a price-to-earnings ratio of 39.7 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of $8.06 is built from several models across several years. Other multiples: P/B 25.4, P/S 6.7, EV/EBITDA 33.9.
How solid is the balance sheet of Buda Juice, Inc. (BUDA)?
Balance-sheet figures for Buda Juice, Inc. (as of Sep 24, 2026): return on equity 19.3%. They feed the Quality Score of 81/100, which measures business quality independently of the share price.
Which stocks are comparable to Buda Juice, Inc.?
From the same area (Consumer Defensive) we also value The Coca-Cola Company, PepsiCo, Inc, Monster Beverage Corporation, Nongfu Spring Co, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Buda Juice, Inc. stock attractive at the current price?
The data as of Sep 24, 2026: price $7.55, calculated fair value $8.06 (+7%), Quality Score 81/100, from 24 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of BUDA calculated?
We run Buda Juice, Inc. through 24 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $8.06, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 13.0 % above its aggregate fair value. Buda Juice, Inc. currently trades 7 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Buda Juice, Inc. (BUDA)?
The closing price on Sep 23, 2026 was $7.55. Our model-based fair value is $8.06, about +7% upside (fairly valued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Buda Juice, Inc. right now?
The model range is unusually wide ($5.00 to $13.24). The outcome hinges heavily on assumptions, so read the point estimate with caution. The price sits close to our fair value, market and models broadly agree here, little valuation tension.

Key figures of Buda Juice, Inc.

How large is the market capitalisation of Buda Juice, Inc. (BUDA)?
The market capitalisation of Buda Juice, Inc. is $94.9M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Buda Juice, Inc. (BUDA)?
The price-to-sales ratio of Buda Juice, Inc. is 11.1 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of Buda Juice, Inc. (BUDA)?
Earnings per share at Buda Juice, Inc. are $0.1900 (price ÷ EPS = P/E 39.7). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of Buda Juice, Inc. (BUDA)?
The dividend yield of Buda Juice, Inc. is 3.0% (payout 120%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of Buda Juice, Inc. (BUDA)?
The net margin of Buda Juice, Inc. is 28.0% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of Buda Juice, Inc. (BUDA)?
The return on equity (ROE) of Buda Juice, Inc. is 19.3% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Buda Juice, Inc. (BUDA)?
On an EBIT basis the return on assets of Buda Juice, Inc. is 80.7% (avg 3y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Buda Juice, Inc. (BUDA)?
The operating margin of Buda Juice, Inc. is 9.9% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Buda Juice, Inc. (BUDA)?
Revenue at Buda Juice, Inc. is growing +26.4% versus a year earlier. How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at Buda Juice, Inc. (BUDA)?
Earnings per share at Buda Juice, Inc. are growing −20.0% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does Buda Juice, Inc. (BUDA) hold?
Buda Juice, Inc. holds more cash than debt, $1.1M net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch Buda Juice, Inc. in the live analysis

One click puts Buda Juice, Inc. on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.